Company: LGN
Filing Date: 2025-02-14
Form Type: DRS
Source: 0000950123-25-002471
Chunk: 93

Company: Legence Corp.
Filing Date: 2025-02-14
Form: DRS
Chunk 93
---
                                           |

| • |     | the expected future value of our intangible assets; |

| • |     | expectations regarding the future availability and price of materials and equipment necessary for the performance 
 of our business;                                                                                                  |

| • |     | the expected impact of global and domestic economic or political conditions on our business, financial condition,                                                      
 results of operations, cash flows, liquidity, and demand for our services, including inflation, interest rates, recessionary economic conditions and commodity prices; |

| • |     | the expected impact of changes and potential changes in climate and the physical and transition risks associated 
 with climate change;                                                                                             |

| • |     | the expected impact of existing or potential legislation or regulation; |

| • |     | the future demand for, availability of and costs related to labor resources in the industries we serve; |

| • |     | the expected recognition and realization of our remaining performance obligations or backlog; |

58

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

| • |     | credit markets; |

| • |     | our pending legal matters; and |

| • |     | our plans, objectives, expectations and intentions contained in this prospectus that are not historical. |

We caution you that these forward-looking statements are subject to all of the risks and uncertainties incident to the business in which we operate, most of which are difficult to predict and many of which are beyond our control. These risks include, but are not limited to, the risks described under “Risk Factors.” Should one or more of the risks or uncertainties described in this prospectus occur, or should underlying assumptions prove incorrect, our actual results and plans could differ materially from those expressed in any forward-looking statements. All forward-looking statements, expressed or implied, included in this prospectus are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this prospectus. 59

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

USE OF PROCEEDS

We expect to receive approximately $ million (or approximately $